LEVEMIR Side Effects

6783260-1 | Intestinal Obstruction
on Jun 13, 2010 Female patient from ISRAEL , 83 years of age, weighting 125.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction. Levemir dosage: 6 U, Qd. Patient was hospitalized.

6774154-6 | Blood Glucose Decreased, Blood Glucose Fluctuation, Convulsion, Incorrect Dose Administered, Laceration
Patient was taking Levemir (View Usage). Patient had the following side effects: blood glucose decreased, blood glucose fluctuation, convulsion, incorrect dose administered, laceration on Jun 08, 2010 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 190.0 lb, was diagnosed with diabetes mellitus and. Levemir dosage: 42 U, Qd At Bedtime. During the same period patient was treated with NOVOLOG (Unk) (View Novolog Review and Novolog Label ), NOVOLIN R (Unk) (View Novolin R Review and Novolin R Label ).

6774153-4 | Hypoglycaemic Unconsciousness, Renal Failure Chronic, Shock Hypoglycaemic
Adverse event was reported on Jun 07, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 20 U, Unk) was diagnosed with insulin-requiring type 2 diabetes mellitus, hypertension, blood cholesterol increased and. Location: UNITED STATES , weighting 170.0 lb, After Levemir was administered, patient had the following side effects: hypoglycaemic unconsciousness, renal failure chronic, shock hypoglycaemic. During the same period patient was treated with NOVOLOG (20 U, Qd) (View Novolog Review and Novolog Label ), CLONIDINE (0.1 Mg, Qid) (View Clonidine Review and Clonidine Label ), CALCITRIOL (.25 Mg, Qd) (View Calcitriol Review and Calcitriol Label ), FUROSEMIDE (40 Mg, Bid) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (80 Mg, Bid) (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (5 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (10 Mg, Qd) (View Amlodipine Review and Amlodipine Label ).

6769436-8 | Blood Glucose Fluctuation, Headache
on Jun 09, 2010 Female patient from UNITED STATES , weighting 224.0 lb, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, headache (What is headache?). Levemir dosage: 85 Iu, Qd. During the same period patient was treated with NOVOLOG (34 Iu, Qd (7 Iu Morning, 12 Iu Afternoon, 15 Iu Evening)) (View Novolog Review and Novolog Label ), VICTOZA (0.6 Mg, Qd) (View Victoza Review and Victoza Label ).


6769431-9 | Pancreatic Carcinoma
on Jun 05, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: pancreatic carcinoma. Levemir dosage: .

6765174-6 | Hypersensitivity, Injection Site Rash, Rash Macular
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: hypersensitivity, injection site rash, rash macular on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 1904 lb, was diagnosed with diabetes mellitus and. Levemir dosage: 10 Units Once At Night Levemir. Patient was hospitalized.

6757750-1 | Blood Glucose Increased, Myocardial Infarction
Adverse event was reported on Apr 12, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 75 U, Bid) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 42 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, myocardial infarction. Patient was hospitalized.

6757698-2 | Anti-insulin Antibody, Diabetes Mellitus Inadequate Control, Hypoglycaemia
on May 26, 2010 Female patient from JAPAN , 48 years of age, weighting 112.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: anti-insulin antibody, diabetes mellitus inadequate control, hypoglycaemia. Levemir dosage: /sc. During the same period patient was treated with NOVORAPID CHU FLEXPEN (/sc) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN R (/sc) (View Novolin R Review and Novolin R Label ), NOVOLIN N (Unk) (View Novolin N Review and Novolin N Label ). Patient was hospitalized.

6755696-6 | Glucagonoma, Hypoglycaemia, Metastases To Liver, Pneumonia Aspiration, Unresponsive To Stimuli
on May 27, 2010 Female patient from JAPAN , weighting 112.4 lb, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: glucagonoma, hypoglycaemia, metastases to liver, pneumonia aspiration, unresponsive to stimuli. Levemir dosage: 25 Iu, Unk. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ), VOGLIBOSE (0.6 Mg, Unk) (View Voglibose Review and Voglibose Label ), METFORMIN (1500 Mg, Unk) (View Metformin Review and Metformin Label ), LIPITOR (5 Mg, Unk) (View Lipitor Review and Lipitor Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), PANCREATIN (10 G, Unk) (View Pancreatin Review and Pancreatin Label ), PANVITAN /05664201/ (1 G, Unk) (View Panvitan /05664201/ Review and Panvitan /05664201/ Label ), BIOFERMIN R (2 G, Unk) (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

6753168-6 | Cardiac Arrest
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?) on May 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with type 2 diabetes mellitus, angina pectoris, hypercholesterolaemia, dyspepsia and. Levemir dosage: 52 U, Qd. During the same period patient was treated with BISOPROLOL (1.25 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), ATORVASTATIN (20 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), LANSOPRAZOLE (15 Mg, Qd) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6749847-7 | Asymptomatic Bacteriuria, Condition Aggravated, Diabetic Nephropathy, Pregnancy Induced Hypertension
Adverse event was reported on May 24, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 28 U, Qd) was diagnosed with type 1 diabetes mellitus, pregnancy induced hypertension and. Location: CROATIA (local name: Hrvatska) , 37 years of age, Patient had the following side effects: asymptomatic bacteriuria, condition aggravated, diabetic nephropathy, pregnancy induced hypertension. During the same period patient was treated with NOVORAPID FLEXPEN (32 U, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), INSULATARD (Unk) (View Insulatard Review and Insulatard Label ), RAMIPRIL (2.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ), CORDIPIN (View Cordipin Review and Cordipin Label ).

6748898-6 | Hepatic Function Abnormal
on May 20, 2010 Male patient from JAPAN , 61 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, diabetic ketoacidosis and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: hepatic function abnormal. Levemir dosage: 8 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (30 U, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), VEEN F (2500 Ml, Qd) (View Veen-f Review and Veen-f Label ), HUMULIN R (40 U, Qd) (View Humulin R Review and Humulin R Label ), SOLITA T3 (Unk) (View Solita-t3 Review and Solita-t3 Label ). Patient was hospitalized.

6747791-2 | Liver Disorder
on May 19, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Levemir dosage: /sc. During the same period patient was treated with NOVORAPID CHU FLEXPEN (/sc) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ).

6745808-2 | Hypoglycaemic Unconsciousness, Sick Sinus Syndrome
Patient was taking Levemir (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness, sick sinus syndrome on May 20, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 24 U, Qd. During the same period patient was treated with NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ), COVERSYL /00790701/ (4 Mg, Qd) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), DOXAZOSIN MESYLATE (2 Mg, Qd) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), OLMESARTAN MEDOXOMIL (20 Mg, Qd) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ARTIST (15 Mg, Qd) (View Artist Review and Artist Label ), KINEDAK (150 Mg, Qd) (View Kinedak Review and Kinedak Label ), METHYLCOBAL (1500 Mg, Qd) (View Methylcobal Review and Methylcobal Label ). Patient was hospitalized.

6745675-7 | Blood Glucose Increased, Blood Ketone Body, Device Breakage, Malaise, Syncope, Underdose
Adverse event was reported on May 17, 2010 by a Female patient taking Levemir (View Usage) (Dosage: Unk) was diagnosed with type 1 diabetes mellitus and. Location: UNITED KINGDOM , 31 years of age, After Levemir was administered, patient had the following side effects: blood glucose increased, blood ketone body, device breakage, malaise, syncope, underdose. During the same period patient was treated with NOVORAPID PENFILL (Unk) (View Novorapid Penfill Review and Novorapid Penfill Label ), SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ).

6743442-1 | Anti-insulin Antibody, Diabetes Mellitus Inadequate Control
on May 17, 2010 Female patient from JAPAN , 48 years of age, weighting 112.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody, diabetes mellitus inadequate control. Levemir dosage: /sc. During the same period patient was treated with NOVORAPID CHU FLEXPEN (/sc) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN R (/sc) (View Novolin R Review and Novolin R Label ), NOVOLIN N (Unk) (View Novolin N Review and Novolin N Label ). Patient was hospitalized.

6735691-3 | Localised Intraabdominal Fluid Collection, Oedema Peripheral
on May 12, 2010 Female patient from UNITED STATES , weighting 187.0 lb, was diagnosed with type 2 diabetes mellitus, mitral valve stenosis and was treated with Levemir (View Usage). Patient had the following side effects: localised intraabdominal fluid collection, oedema peripheral. Levemir dosage: . During the same period patient was treated with NOVOLOG MIX 70/30 (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ), HUMALOG (View Humalog Review and Humalog Label ), AMARYL (View Amaryl Review and Amaryl Label ), LASIX (View Lasix Review and Lasix Label ).

6735366-0 | Hepatic Function Abnormal
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: hepatic function abnormal on May 13, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, diabetic ketoacidosis and. Levemir dosage: 8 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (30 U, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), VEEN F (2500 Ml, Qd) (View Veen-f Review and Veen-f Label ), HUMULIN R (40 U, Qd) (View Humulin R Review and Humulin R Label ), SOLITA T3 (Unk) (View Solita-t3 Review and Solita-t3 Label ).

6735363-5 | Abdominal Discomfort, Hypertransaminasaemia, Lipohypertrophy
Adverse event was reported on May 13, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 7 Iu, Qd) was diagnosed with type 1 diabetes mellitus, chronic hepatitis, abdominal discomfort and. Location: BULGARIA , child 12 years of age, weighting 81.57 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, hypertransaminasaemia, lipohypertrophy. During the same period patient was treated with NOVORAPID (18 Iu, Qd) (View Novorapid Review and Novorapid Label ), KREON /00014701/ (View Kreon /00014701/ Review and Kreon /00014701/ Label ), ENTEROL /01686601/ (250 Mg, Unk) (View Enterol /01686601/ Review and Enterol /01686601/ Label ), URSO FALK (500 Mg, Unk) (View Urso Falk Review and Urso Falk Label ), CARSIL (Unk) (View Carsil Review and Carsil Label ), MEPRESOR (60 Mg, Unk) (View Mepresor Review and Mepresor Label ), MOTILIUM /00498201/ (15 Mg, Unk) (View Motilium /00498201/ Review and Motilium /00498201/ Label ), LINEX (Unk) (View Linex Review and Linex Label ). Patient was hospitalized.

6734026-X | Gastric Cancer
on May 10, 2010 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: gastric cancer. Levemir dosage: 16 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (30 U, Unk) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (1 Mg, Qd) (View Warfarin Potassium Review and Warfarin Potassium Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), FAMOTIDINE (20 Mg, Qd) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6728538-2 | Adenocarcinoma Pancreas, Diabetic Ketoacidosis
on May 10, 2010 Female patient from UNITED STATES , 75 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: adenocarcinoma pancreas, diabetic ketoacidosis. Levemir dosage: Unk. During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6723606-3 | Antepartum Haemorrhage, Placenta Praevia, Pregnancy
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: antepartum haemorrhage, placenta praevia, pregnancy (What is pregnancy?) on May 03, 2010 from SOUTH AFRICA Additional patient health information: Female patient , weighting 200.6 lb, . Levemir dosage: 21 Iu, Qd. During the same period patient was treated with NOVORAPID (27 Iu, Qd) (View Novorapid Review and Novorapid Label ), PROZAC /00724401/ (60 Mg, Qd) (View Prozac /00724401/ Review and Prozac /00724401/ Label ), ZYPREXA (5 Mg, Qd) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

6723598-7 | Premature Baby
Adverse event was reported on May 04, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 52 Iu During Pregnancy) was diagnosed with type 2 diabetes mellitus and. Location: NETHERLANDS , weighting 7.85 lb, Patient had the following side effects: premature baby. During the same period patient was treated with NOVORAPID PENFILL (118 Iu During Pregnancy) (View Novorapid Penfill Review and Novorapid Penfill Label ).

6712960-4 | Caesarean Section
on Apr 29, 2010 Female patient from SLOVAKIA (Slovak Republic) , weighting 116.8 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: caesarean section. Levemir dosage: 39 U, Bid. During the same period patient was treated with NOVORAPID (54 U, Tid) (View Novorapid Review and Novorapid Label ).

6709210-1 | Cataract
on Apr 23, 2010 Female patient from UNITED STATES , 79 years of age, weighting 148.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?). Levemir dosage: 15 Iu, Qd. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), METOPROLOL (50 Mg, Qd) (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6702898-0 | Blood Glucose Decreased, Blood Glucose Increased, Loss Of Consciousness
Patient was taking Levemir (View Usage). Patient had the following side effects: blood glucose decreased, blood glucose increased, loss of consciousness on Apr 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 154.0 lb, was diagnosed with type 2 diabetes mellitus, hypothyroidism, prophylaxis and. Levemir dosage: 10 U, Qd. During the same period patient was treated with ACTOS (15 Mg, Qd) (View Actos Review and Actos Label ), METFORMIN (Unk) (View Metformin Review and Metformin Label ), LEVOTHYROXINE (Unk) (View Levothyroxine Review and Levothyroxine Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6702738-X | Anti-insulin Antibody Positive, Diabetes Mellitus Inadequate Control
Adverse event was reported on Apr 19, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 8 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: JAPAN , 76 years of age, After Levemir was administered, patient had the following side effects: anti-insulin antibody positive, diabetes mellitus inadequate control. During the same period patient was treated with HUMALOG (13 Iu, Qd) (View Humalog Review and Humalog Label ).

6701631-6 | Blood Glucose Increased, Gastroenteritis
on Apr 21, 2010 Female patient from UNITED STATES , weighting 102.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, gastroenteritis (What is gastroenteritis?). Levemir dosage: 3u Am, 7u Pm. During the same period patient was treated with NOVOLOG (Unk) (View Novolog Review and Novolog Label ).

6701621-3 | Abdominal Pain, Blood Glucose Increased
on Apr 19, 2010 Male patient from AUSTRALIA , 20 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood glucose increased. Levemir dosage: . During the same period patient was treated with NOVORAPID (Unk) (View Novorapid Review and Novorapid Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6699890-1 | Anti-insulin Antibody Positive, Diabetes Mellitus Inadequate Control
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: anti-insulin antibody positive, diabetes mellitus inadequate control on Apr 19, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with type 1 diabetes mellitus and. Levemir dosage: 6 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (18 U, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ). Patient was hospitalized.

6699882-2 | Gastric Cancer
Adverse event was reported on Apr 19, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 16 U, Qd) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: gastric cancer. During the same period patient was treated with LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (1 Mg, Qd) (View Warfarin Potassium Review and Warfarin Potassium Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), FAMOTIDINE (20 Mg, Qd) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6693726-0 | Cerebrovascular Accident
on Mar 23, 2010 Male patient from UNITED STATES , weighting 145.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: cerebrovascular accident. Levemir dosage: Unk. Patient was hospitalized.

6691464-1 | Blood Glucose Increased, Myocardial Infarction
on Apr 12, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: blood glucose increased, myocardial infarction. Levemir dosage: 75 U, Bid. Patient was hospitalized.

6689090-3 | Sick Sinus Syndrome
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: sick sinus syndrome on Apr 13, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 26 U, Qd. During the same period patient was treated with NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ), COVERSYL /00790701/ (4 Mg, Qd) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), DOXAZOSIN MESYLATE (2 Mg, Qd) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), OLMESARTAN MEDOXOMIL (20 Mg, Qd) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ARTIST (15 Mg, Qd) (View Artist Review and Artist Label ), KINEDAK (150 Mg, Qd) (View Kinedak Review and Kinedak Label ), METHYLCOBAL (1500 Mg, Qd) (View Methylcobal Review and Methylcobal Label ). Patient was hospitalized.

6687874-9 | Caesarean Section
Adverse event was reported on Apr 09, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 39 U, Bid) was diagnosed with type 1 diabetes mellitus and. Location: SLOVAKIA (Slovak Republic) , weighting 116.8 lb, Patient had the following side effects: caesarean section. During the same period patient was treated with NOVORAPID (54 U, Tid) (View Novorapid Review and Novorapid Label ).

6686094-1 | Anti-insulin Antibody Positive, Diabetes Mellitus Inadequate Control
on Apr 08, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: anti-insulin antibody positive, diabetes mellitus inadequate control. Levemir dosage: 8 Iu, Qd. During the same period patient was treated with HUMALOG (13 Iu, Qd) (View Humalog Review and Humalog Label ). Patient was hospitalized.

6684421-2 | Blood Glucose Decreased, Blood Glucose Fluctuation, Gangrene
on Apr 06, 2010 Male patient from UNITED STATES , weighting 125.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, cardiac disorder and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose fluctuation, gangrene. Levemir dosage: 80 Iu, Qd. During the same period patient was treated with NOVOLOG (Sliding Scale) (View Novolog Review and Novolog Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6682520-2 | Atrial Septal Defect, Cryptorchism, Hypoglycaemia, Patent Ductus Arteriosus, Transposition Of The Great Vessels, Ventricular Septal Defect
Patient was taking Levemir (View Usage). Patient had the following side effects: atrial septal defect, cryptorchism, hypoglycaemia, patent ductus arteriosus, transposition of the great vessels, ventricular septal defect on Apr 07, 2010 from SOUTH AFRICA Additional patient health information: Male patient , weighting 7.67 lb, was diagnosed with type 1 diabetes mellitus and. Levemir dosage: 14 U, Unk. During the same period patient was treated with NOVORAPID FLEXPEN (9 U, Unk) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), PROGESTERONE (Unk) (View Progesterone Review and Progesterone Label ), CELESTONE /00008501/ (Unk) (View Celestone /00008501/ Review and Celestone /00008501/ Label ). Patient was hospitalized.

6682510-X | Jaundice Extrahepatic Obstructive, Pancreatic Neoplasm
Adverse event was reported on Apr 06, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 31 Iu, Qd) was diagnosed with type 2 diabetes mellitus and. Location: MEXICO , 76 years of age, weighting 104.7 lb, After Levemir was administered, patient had the following side effects: jaundice extrahepatic obstructive, pancreatic neoplasm. During the same period patient was treated with NOVORAPID FLEXPEN (6-9 Iu, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), TRAMACET /01573601/ (100 Mg, Qd) (View Tramacet /01573601/ Review and Tramacet /01573601/ Label ), ACETYLSALICYLIC ACID (100 Mg, Qd) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6676543-7 | Gastric Cancer
on Apr 06, 2010 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: gastric cancer. Levemir dosage: 16 U, Qd. During the same period patient was treated with LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), WARFARIN POTASSIUM (1 Mg, Qd) (View Warfarin Potassium Review and Warfarin Potassium Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), FAMOTIDINE (20 Mg, Qd) (View Famotidine Review and Famotidine Label ).

6676527-9 | Anxiety, Blood Glucose Increased, Electrocardiogram Qt Prolonged, Heart Rate Increased
on Apr 01, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood glucose increased, electrocardiogram qt prolonged, heart rate increased. Levemir dosage: 55 Iu, Qd. During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ). Patient was hospitalized.

6663343-7 | Jaundice Extrahepatic Obstructive, Pancreatic Neoplasm
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: jaundice extrahepatic obstructive, pancreatic neoplasm on Mar 30, 2010 from MEXICO Additional patient health information: Female patient , 76 years of age, weighting 104.7 lb, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 31 Iu, Qd. During the same period patient was treated with NOVORAPID FLEXPEN (6-9 Iu, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), TRAMACET /01573601/ (100 Mg, Qd) (View Tramacet /01573601/ Review and Tramacet /01573601/ Label ).

6660799-0 | Cerebrovascular Accident
Adverse event was reported on Mar 23, 2010 by a Male patient taking Levemir (View Usage) (Dosage: Unk) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Patient was hospitalized.

6660791-6 | Blood Glucose Increased, Heart Rate Increased, Heart Rate Irregular, Ventricular Extrasystoles
on Mar 23, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: blood glucose increased, heart rate increased, heart rate irregular, ventricular extrasystoles. Levemir dosage: 55 Iu, Qd. Patient was hospitalized.

6660655-8 | Abdominal Discomfort, Hypertransaminasaemia
on Mar 22, 2010 Female patient from BULGARIA , child 12 years of age, weighting 81.57 lb, was diagnosed with type 1 diabetes mellitus, chronic hepatitis, abdominal discomfort and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: abdominal discomfort, hypertransaminasaemia. Levemir dosage: 7 Iu, Qd. During the same period patient was treated with NOVORAPID (18 Iu, Qd) (View Novorapid Review and Novorapid Label ), KREON /00014701/ (View Kreon /00014701/ Review and Kreon /00014701/ Label ), ENTEROL /01686601/ (250 Mg, Unk) (View Enterol /01686601/ Review and Enterol /01686601/ Label ), URSO FALK (500 Mg, Unk) (View Urso Falk Review and Urso Falk Label ), CARSIL (Unk) (View Carsil Review and Carsil Label ), MEPRESOR (60 Mg, Unk) (View Mepresor Review and Mepresor Label ), MOTILIUM /00498201/ (15 Mg, Unk) (View Motilium /00498201/ Review and Motilium /00498201/ Label ), LINEX (Unk) (View Linex Review and Linex Label ). Patient was hospitalized.

6660652-2 | Foetal Growth Retardation
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: foetal growth retardation on Mar 26, 2010 from CROATIA (local name: Hrvatska) Additional patient health information: Female patient , weighting 4.14 lb, was diagnosed with type 1 diabetes mellitus, pregnancy induced hypertension and. Levemir dosage: 28 U, Qd. During the same period patient was treated with NOVORAPID FLEXPEN (32 U, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), INSULATARD (Unk) (View Insulatard Review and Insulatard Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ), CORDIPIN (View Cordipin Review and Cordipin Label ).

6660460-2 | Asymptomatic Bacteriuria, Condition Aggravated, Diabetic Nephropathy, Pregnancy Induced Hypertension
Adverse event was reported on Mar 26, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 28 U, Qd) was diagnosed with type 1 diabetes mellitus, pregnancy induced hypertension and. Location: CROATIA (local name: Hrvatska) , 37 years of age, Patient had the following side effects: asymptomatic bacteriuria, condition aggravated, diabetic nephropathy, pregnancy induced hypertension. During the same period patient was treated with NOVORAPID FLEXPEN (32 U, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), INSULATARD (Unk) (View Insulatard Review and Insulatard Label ), RAMIPRIL (2.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ), CORDIPIN (View Cordipin Review and Cordipin Label ).

6660459-6 | Anti-insulin Antibody Increased, Hyperglycaemia
on Mar 25, 2010 Male patient from JAPAN , child 11 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: anti-insulin antibody increased, hyperglycaemia. Levemir dosage: 40 Iu, Qd. During the same period patient was treated with NOVORAPID CHU PENFILL (/sc) (View Novorapid Chu Penfill Review and Novorapid Chu Penfill Label ). Patient was hospitalized.

6653640-3 | Blood Glucose Fluctuation, Pre-eclampsia, Premature Rupture Of Membranes
on Mar 15, 2010 Female patient from GERMANY , weighting 112.4 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, pre-eclampsia, premature rupture of membranes. Levemir dosage: Unk, Qd. During the same period patient was treated with MANINIL (View Maninil Review and Maninil Label ), ANTIFUNGOL /00212501/ (View Antifungol /00212501/ Review and Antifungol /00212501/ Label ), VOMEX A /00019501/ (View Vomex A /00019501/ Review and Vomex A /00019501/ Label ), CEFUROXIM /00454602/ (View Cefuroxim /00454602/ Review and Cefuroxim /00454602/ Label ). Patient was hospitalized.

6647985-0 | Glucagonoma, Hypoglycaemia, Pneumonia Aspiration
Patient was taking Levemir (View Usage). Patient had the following side effects: glucagonoma, hypoglycaemia, pneumonia aspiration on Mar 19, 2010 from JAPAN Additional patient health information: Female patient , weighting 112.4 lb, was diagnosed with diabetes mellitus and. Levemir dosage: 25 Iu, Unk. During the same period patient was treated with VOGLIBOSE (0.6 Mg, Unk) (View Voglibose Review and Voglibose Label ), METFORMIN HCL (1500 Mg, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), LIPITOR (5 Mg, Unk) (View Lipitor Review and Lipitor Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), PANCREATIN (10 G, Unk) (View Pancreatin Review and Pancreatin Label ), PANVITAN /05664201/ (1 G, Unk) (View Panvitan /05664201/ Review and Panvitan /05664201/ Label ), BIOFERMIN R (2 G, Unk) (View Biofermin R Review and Biofermin R Label ), THYRADIN (100 Ug, Unk) (View Thyradin Review and Thyradin Label ). Patient was hospitalized.